Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2881
    PDF: 1022
    HTML: 40
  • Improvement of atopic dermatitis and alopecia universalis with dupilumab

    Lama Alotaibi, Abdulrahman Alfawzan, Raghad Alharthi, Afaf Al sheikh
    28-12-2021
    https://doi.org/10.4081/dr.2022.9359
    1434
    PDF: 599
    HTML: 56
  • Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

    Filippo Chersi, Sanja Javor, Rosella Gallo, Elia Sala, Cesare Massone
    28-02-2025
    https://doi.org/10.4081/dr.2025.10214
    1033
    PDF: 776
    HTML: 16
  • A rare case of keloid combined with bullous pemphigoid

    Ying Zhang, Yiyi Gong, Xiangguang Shi, Huyan Chen, Yining Wei, Wenyu Wu, Mengguo Liu
    09-10-2025
    https://doi.org/10.4081/dr.2025.10484
    1196
    PDF: 318
    HTML: 11
  • Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

    Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi
    16-10-2025
    https://doi.org/10.4081/dr.2025.10588
    503
    PDF: 248
    HTML: 5
  • Acute generalized exanthematous pustulosis triggered by dupilumab

    Caterina Mariarosaria Giorgio, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Anna Balato, Eugenia Veronica Di Brizzi
    23-07-2025
    https://doi.org/10.4081/dr.2025.10219
    570
    PDF: 373
    HTML: 29
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2549
    PDF: 1466
    HTML: 129
  • Eosinophilic annular erythema: four additional cases and a review of the literature on therapeutic options

    Andrea Corio, Simona Sola, Iris Zalaudek, Cesare Massone
    16-01-2026
    https://doi.org/10.4081/dr.2026.10168
    1052
    PDF: 457
    SUPPLEMENTARY MATERIAL: 14
    HTML: 0
  • Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report

    Arlind Kalaja, Barbara Cocuroccia, Donatella Sordi, Anna Dattolo, Sabatino Pallotta, Ignazio Stanganelli, Filomena Russo
    04-06-2026
    https://doi.org/10.4081/dr.2026.10522
    423
    PDF: 243
  • The anxiety and depression disorder in adults with atopic dermatitis: experience of a dermatology hospital

    Ngo Minh Vinh , Vu Thi Thuy Trang, Luong Nguyen Dac Thuy, Huynh Thi Xuan Tam , Le Thi Thuy Hang , Pham Van Bac
    06-07-2022
    https://doi.org/10.4081/dr.2022.9524
    2187
    PDF: 817
    HTML: 36
  • 29 | INNOVATIVE THERAPEUTIC STRATEGIES IN GENODERMATOSIS: AN ITALIAN MULTICENTRE STUDY F. Pavan1, F. Cassalia2, S. Giordano3, A. Gelmetti4, L. Ventura5, F. Caroppo2, A. Bassi6, F. Martorana7, R. Balestri8, A. Guglielmo9, F. Ambrogio10, A. Bonvicino3, I. Neri4, P. Quaglino3, A. Belloni Fortina11 | 1Pediatrics Unit, Department of Women’s and Child’s Health (SDB), University of Padua, Italy; 2Dermatology Unit, Department of Medicine (DIMED), University of Padua, Italy; 3Department of Medical Sciences, Section of Dermatology, University of Turin, Italy; 4Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Italy; 5Department of Statistical Science, University of Padua, Italy; 6Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; 7Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II; 8Division of Dermatology, Outpatient Consultation for Rare Diseases, APSS, Trento, Italy; 9Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; 10Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, Italy; 11Pediatric Dermatology Department of Women’s and Child’s Health (SDB), University of Padua, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11091
    122
    PDF: 55
  • Hidradenitis suppurativa characterized by type 2-skewed inflammatory features when associated with atopic dermatitis: critical appraisal of a dupilumab-treated case report

    Niccolò Gori, Elena Ippoliti, Flaminia Antonelli, Ludovica Manieri, Ketty Peris
    15-07-2026
    https://doi.org/10.4081/dr.2026.10292
    388
    PDF: 218
  • Underrepresentation of atopic dermatitis publications in pediatric journals: a bibliometric analysis

    Barak Zlakishvili, Sarah Weissmann, Amir Horev
    12-04-2024
    https://doi.org/10.4081/dr.2024.9932
    766
    PDF: 564
    SUPPLEMENTARY MATERIAL: 182
    HTML: 25
  • Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies

    Claudia Paganini, Edoardo Mortato, Lorenzo Tofani, Alfredo Belcastro, Marina Talamonti, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo
    04-03-2025
    https://doi.org/10.4081/dr.2025.10193
    1431
    PDF: 632
    HTML: 50
  • Dupilumab as a targeted therapeutic strategy for Th2-driven cutaneous manifestations in Kimura disease

    Gaetano Licata, Anna Balato, Giuseppe Argenziano, Caterina Mariarosaria Giorgio
    22-07-2026
    https://doi.org/10.4081/dr.2026.10839
    224
    PDF: 148
  • 67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; 5Chang Gung University College of Medicine, Taoyuan, Taiwan; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; 8Department of Dermatology and Population Health Sciences, King’s College London, UK; 9Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; 11Eli Lilly and Company, Indianapolis, Indiana, USA; 12Almirall R&D, S.A., Barcelona, Spain; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11114
    166
    PDF: 97
  • Asian herbal medicine for atopic dermatitis: a systematic review

    Nikko Vanda Limantara, Ronggo Sadono, Suci Widhiati, Retno Danarti
    25-08-2023
    https://doi.org/10.4081/dr.2023.9727
    2136
    PDF: 981
    HTML: 64
  • 10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11077
    231
    PDF: 161
  • 30 | ATOPIC DERMATITIS AND ULCERATIVE COLITIS: A CASE REPORT ON THE MANAGEMENT OF OVERLAPPING COMORBIDITIES S. Senatore1, C. Cardinali1, A. Pieraccini2, F. Taviti1 | 1SOC Dermatologia Pistoia-Prato, USL Toscana Centro, Italy; 2SOC Gastroenterologia ed Endoscopia, USL Toscana Centro, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11092
    229
    PDF: 96
  • 12 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, US; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, US; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CA; 5Chang Gung University College of Medicine, Taoyuan, TW; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JP; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, DE; 8Department of Dermatology and Population Health Sciences, King’s College London, London, UK; 9Ada West Dermatology, St Luke's Children's Hospital, Idaho, US; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AU; 11Eli Lilly and Company, Indianapolis, Indiana,US; 12Almirall R&D, S.A., Barcelona, ES; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, US

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11079
    244
    PDF: 78
  • Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

    Ashjan Alheggi, Raneem Alnutaifi, Manal Alkhonezan, Norah Almudawi, Renad Alsuhaibani, Philip Moons, Turki Aljuhani
    18-05-2023
    https://doi.org/10.4081/dr.2023.9700
    1243
    PDF: 406
    APPENDIX S1: 226
    HTML: 20
  • Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

    Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi
    21-02-2025
    https://doi.org/10.4081/dr.2025.10278
    526
    PDF: 338
    HTML: 29
  • Scabies mimicking relapsing atopic dermatitis

    Flavia Pigliacelli, Elva Abril, Norma Cameli, Paolo Iacovelli, Maria Mariano
    09-08-2024
    https://doi.org/10.4081/dr.2024.10070
    1128
    PDF: 730
    HTML: 124
  • Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

    Raghavendra KR, Bangaru H
    06-07-2022
    https://doi.org/10.4081/dr.2022.9525
    2202
    PDF: 603
    HTML: 75
  • Translation and validation of patient-oriented eczema measure in the Greek language

    Garyfallia Stefanou, Stamatios Gregoriou, Mihalis Bakakis, Styliani Mastraftsi, Alexandros Stratigos, Stathis Kontodimas, Konstantinos Sfaelos, Georgia Kourlaba
    11-10-2023
    https://doi.org/10.4081/dr.2023.9689
    928
    PDF: 538
    HTML: 33
1 - 25 of 25 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.